Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$2.1 - $4.12 $18,259 - $35,823
-8,695 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$2.42 - $4.42 $3,937 - $7,191
-1,627 Reduced 15.76%
8,695 $34,000
Q4 2021

Feb 15, 2022

SELL
$3.95 - $7.53 $7,568 - $14,427
-1,916 Reduced 15.66%
10,322 $42,000
Q3 2021

Nov 15, 2021

SELL
$6.83 - $13.58 $132,174 - $262,800
-19,352 Reduced 61.26%
12,238 $84,000
Q2 2021

Aug 16, 2021

BUY
$6.98 - $13.33 $220,498 - $421,094
31,590 New
31,590 $355,000

Others Institutions Holding CLNN

About Clene Inc.


  • Ticker CLNN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 63,502,000
  • Market Cap $273M
  • Description
  • Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug is CNM-Au8, which is being studied in various clinical trials, including a Phase 2/3 registrational clinical trial for patients with amyotrophic lateral scleros...
More about CLNN
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.